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ABSTRACT Although neural circuits mediating various
simple behaviors have been delineated, those generating more
complex behaviors are less well described. The discrete struc-
ture of avian song control nuclei promises that circuits con-
trolling complex behaviors, such as birdsong, can also be
understood. To this end, we developed an in vitro brain slice
preparation containing the robust nucleus of the archistriatum
(RA), a forebrain song control nucleus, and its inputs from two
other song nuclei, the caudal nucleus of the ventral hyperstri-
atum (HVc) and the lateral part of the magnocellular nucleus
of the anterior neostriatum (L-MAN). Using intracellular
recordings, we examined the pharmacological properties of the
synapses made on RA neurons by L-MAN and HVc axons.
Electrical stimulation of the L-MAN and the HVc fiber tracts
evoked excitatory postsynaptic potentials (EPSPs) from >70%
of RA neurons when slices were prepared from male birds of
40-90 days of age, suggesting that many individual RA neurons
receive excitatory input from L-MAN and HVc axons. The
"L-MAN" EPSPs were blocked by the N-methyl-D-aspartate
(NMDA) receptor antagonist D-(-)-2-amino-5-phosphonova-
leric acid (D-APV) as well as the broad-spectrum glutamate
receptor antagonist kynurenic acid but were relatively unaf-
fected by the non-NMDA receptor blocker 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX). In contrast, "HVc" EP-
SPs were relatively insensitive to D-APV but almost completely
abolished by CNQX. These experiments suggest that L-MAN
and HVc axons provide pharmacologically distinct types of
excitatory input to many of the same RA neurons.
The differential activation of N-methyl-D-aspartate (NMDA)
and non-NMDA glutamate receptors can produce pro-
nounced differences in the output patterns of certain neural
circuits (1-3). We report here that two distinct inputs to the
same neuron activate primarily NMDA or non-NMDA re-
ceptors in the robust nucleus of the archistriatum (RA),
which is one ofthe brain areas that controls song in birds. The
neural signals for song descend from the caudal part of the
nucleus of the ventral hyperstriatum (HVc) to the RA and
from there to the tracheosyringeal portion of the hypoglossal
nucleus (nXIIts), which in turn innervates the vocal muscles
used in singing (4-6). This chain of nuclei thus constitutes the
motor pathway for song. The HVc is linked to the RA by
another series of nuclei, which includes area X, the medial
part of the dorsolateral thalamus, and the lateral part of the
magnocellular nucleus of the anterior neostriatum (L-MAN)
(7, 8). This pathway presumably carries auditory information
necessary for the control of song development (9-11). The
RA is thus located at the point of convergence between the
vocal motor and auditory pathways. The colocalization of
two distinct glutamate receptor subtypes at such a location
might have special significance for the well-known vocal
plasticity exhibited by songbirds.
MATERIALS AND METHODS
Brain slices were prepared from 40- to 90-day-old male zebra
finches (Taeniopygia guttata) or Bengalese finches (Lon-
chura striata) obtained from our breeding colony (all dates
refer to posthatch age: the hatch day is posthatch 0). Birds
were anesthetized with ketamine hydrochloride (0.03-0.06
ml), followed by 5-10 min of Metofane (Pitman-Moore,
Washington Crossing, NJ) inhalation, which was discontin-
ued when the respiratory rate decreased markedly. After a
second, larger injection of ketamine (0.06-0.09 ml), the bird
was decapitated. The brain was removed and placed in
ice-cold artificial cerebrospinal fluid (ACSF; see below for
recipes) that had been equilibrated with 95% 02/5% C02. The
brain was blocked transversely about 5 mm rostral of the
bifurcation of the midsagittal sinus, and the caudal half of the
brain was glued (Loctite, Cleveland) rostral face down to the
stainless steel tray of the vibratome. Coronal slices were cut
at 400 ,um thickness and transferred to an interface-type
chamber. The ACSF in the interface chamber was supple-
mented with 0.1% bovine serum albumin (Sigma) and DL-
(-)-2-amino-5-phosphonovaleric acid (DL-APV) to a final
concentration of 100 ,uM. The upper surface of the slice was
exposed to a humidified atmosphere of 95% 02/5% CO2.
After a 1- to 2-hr recovery period, individual brain slices
were transferred to a semisubmersion type recording cham-
ber maintained at 35°C, with a perfusion rate of 3-5 ml/min.
The fluid level was lowered to within <500 1Lm of the upper
surface of the slice. ACSF was warmed to 35°C and gassed
with 95% 02/5% CO2 before entering the chamber. Humid-
ified 95% 02/5% CO2 was also supplied to the recording
chamber.
Anatomical reconstruction has shown that L-MAN and
HVc axons describe different paths to reach RA (personal
observations; see also ref. 8). Although L-MAN and HVc
fibers travel in roughly parallel dorsoventral trajectories
toward RA, L-MAN fibers are displaced laterally to those
arising from HVc. Ultimately, L-MAN axons turn and enter
RA along its lateral face, whereas HVc axons, being more
medially situated, enter RA along its dorsal edge (see Fig. 1).
Therefore, coronal slices containing RA were prepared that
allowed the L-MAN and HVc fiber tracts to be electrically
stimulated independently of one another. Bipolar tungsten
stimulating electrodes were placed <1.0 mm lateral and
dorsal to nucleus RA, in areas containing the L-MAN or HVc
axon tracts entering the nucleus (see Fig. 1). Electrical
Abbreviations: NMDA, N-methyl-D-aspartate; EPSP, excitatory
postsynaptic potential; RA, robust nucleus of the archistriatum;
HVc, caudal nucleus of the ventral hyperstriatum; L-MAN, lateral
part of the magnocellular nucleus of the anterior neostriatum;
CNQX, 6-cyano-7-nitroquinoxaline-2,3-dione; ACSF, artificial cere-
brospinal fluid; APV, 2-amino-5-phosphonovaleric acid.
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FIG. 1. A schematic of the in vitro finch forebrain slice prepa-
ration shows the placement of the intracellular recording electrode in
a RA neuron and the location of the extracellular, bipolar stimulating
electrodes in the L-MAN (lateral) and HVc (dorsal) fiber tracts
entering RA.
stimulation of each fiber tract was accomplished by applying
brief voltages (0.5-20 V), 100 gsec in duration, at a frequency
of 0.1-1 Hz [WPI (New Haven, CT) Pulsemaster], to the
stimulating electrodes.
Drugs were delivered to the slice by switching between
various bathing solutions by means of a solenoid-operated
valve assembly (General Valve, Fairfield, NJ). Alternatively,
a pressure-driven puffer pipette (WPI PicoPump), prepared
from 1-mm capillary glass and drawn to a final tip diameter
of 20-50 ,um, was positioned within 400 gm of the recording
site. Drugs of choice were dissolved in ACSF at known
concentrations and then loaded into the pipette. With this
method, drug concentrations refer to the pipette solution.
The actual bath concentrations were assumed to be substan-
tially lower than the upper limit set by the pipette concen-
tration. D-APV and 6-cyano-7-nitroquinoxaline-2,3-dione
(CNQX) were purchased from Tocris Neuramin (Essex,
England). All other drugs were purchased from Sigma.
RA neurons were impaled with 50- to 150-Mfl electrodes
fabricated on a Brown-Flaming microelectrode puller from
1-mm borosilicate glass (WPI 1B1001F) and filled with 3 M
potassium acetate. The postsynaptic membrane potential was
amplified [NeuroData (New York) IR-283 intracellular ampli-
fier, bridge circuit] and individual events were stored on vid-
eotape in a pulse code format (NeuroData Neuro-Corder DR-
484). Signals were low pass filtered at 5 kHz, digitized at 10 kHz,
signal averaged, and analyzed with the aid of digital oscillo-
scope software written by Larry Proctor (California Institute
of Technology) for a Masscomp (Westford, MA) graphics
workstation. Synaptic potentials are the averages of 6-16 indi-
vidual traces. Measurements of the excitatory postsynaptic
potential (EPSP) slope were calculated over the first millisecond
of the EPSP, starting from the EPSP onset. EPSP amplitudes
were calculated as the maximum positive deflection from base-
line. Quantification ofthe EPSP amplitude reflects the mean, as
normalized to the control value preceding drug treatment,
±SEM. Average values of an EPSP's peak latency and onset
slope were not normalized. Statistical significance was deter-
mined by an unpaired t test (two-tailed). Resting potential was
calculated as the difference between the observed potential
immediately before and after withdrawal of the recording elec-
trode from the cell. In some cases, dc hyperpolarization of the
postsynaptic cell membrane was used to suppress spontane-
ously occurring action potentials.
The ACSF recipe is as follows (all concentrations are mM):
NaCI, 134.0; NaHCO3, 25.7; NaH2PO4, 1.3; KCl, 3.0; MgSO4
(7H20), 1.3; CaCI2(2H20), 2.4; glucose, 12.0; urea, 1.0. For
high divalent ACSF, CaCl2(2H20) and MgSO4(7H20) were
4.0 mM each. For very high divalent ACSF, CaCl2(2H20) and
MgSO4(7H20) were 8 mM each.
RESULTS
The majority ofRA neurons responded to L-MAN and HVc
fiber stimulation (72 of 98 cells in 30 experiments). Electrical
stimulation in the L-MAN and HVc fiber tracts could evoke
depolarizing potentials from such "dually innervated" RA
neurons (two lower amplitude traces in Fig. 2). Since the
depolarizing potentials evoked by stimulating either input by
itself could exceed spike threshold, they were classified as
excitatory (EPSPs). The "L-MAN" and "HVc" EPSPs
recorded from 25 dually innervated RA neurons were ana-
lyzed in greater detail.
A consistent feature of the subthreshold L-MAN and HVc
EPSPs was that their shapes differed from each other, as shown
in Fig. 2. L-MAN EPSPs displayed a shallower onset slope and
took relatively longer to reach peak amplitude, whereas HVc
EPSPs exhibited a steeper onset slope and a substantially
shorter time to peak. In 25 dually innervated RA neurons, the
L-MAN EPSP onset slope averaged 1.06 ± 0.13 mV/msec,
significantly less than the value of 1.57 ± 0.14 mV/msec
obtained for the HVc EPSP (P < 0.009, n = 25). In the same RA
neurons, the time to peak of the L-MAN response, at 12.28 ±
0.89 msec, was significantly longer than the value of7.12 ± 0.76
msec measured for the HVc EPSP (P < 0.0001, n = 25).
L-MAN EPSPs were characterized by a slower initial time
course than those evoked by HVc fiber stimulation.
The interactions between the L-MAN and HVc EPSPs
were examined by stimulating the two fiber pathways simul-
taneously. Since simultaneous stimulation ofthe L-MAN and
HVc fiber pathways often drove the cell past spike threshold,
the individual stimulus intensities were reduced until the
simultaneous stimulation of the two inputs did not evoke an
action potential. The linear sum of the L-MAN and HVc
EPSPs, computed by digitally adding the EPSPs evoked by
stimulating either input alone, was compared to the EPSP
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FIG. 2. Electrical stimulation of the L-MAN and HVc fiber tracts
evoked EPSPs from the majority of RA neurons from which we
recorded. The EPSPs shown here, recorded in vitro from a typical
dually innervated RA neuron, were obtained in a brain slice prepared
from a 50-day-old male finch. The L-MAN EPSP exhibited a
consistently shallower onset slope and longer time to peak than did
the HVc EPSP. The L-MAN and HVc EPSPs summed in a nearly
linear fashion when the two fiber tracts were stimulated simultane-
ously. The actual EPSP observed when driving the two inputs
together (observed sum) slightly exceeded the linear sum of the two
EPSPs obtained when driving each input separately. The cell is
shown at its actual resting potential, recorded in high divalent ACSF.
In all cases, electrical stimuli were applied at t = 10 msec.
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FIG. 3. Kynurenic acid (10 mM applied from a puffer pipette)
substantially reduced the L-MAN and the HVc EPSPs recorded from
dually innervated RA neurons. The cell is shown at its actual resting
potential. Recordings were made in high divalent ACSF; the brain
slice was prepared from a 70-day-old male finch. Stimuli were applied
to the L-MAN or HVc fiber tracts at t = 10 msec.
evoked by stimulating the two inputs simultaneously (ob-
served sum). The results of such a comparison can be seen in
Fig. 2. In six cases analyzed in this manner, the observed sum
closely approximated the linear sum, although in five ofthese
cases, the observed sum actually exceeded the linear sum of
the L-MAN and HVc EPSPs by a slight amount.
The pharmacological nature of the L-MAN and HVc
EPSPs was investigated by applying specific neurotrans-
mitter antagonists to the preparation while recording from
dually innervated RA neurons. Two dually innervated RA
neurons were treated with kynurenic acid (1 mM bath appli-
cation or 10 mM from a puffer pipette), a broad-spectrum
glutamate receptor antagonist (12). Kynurenic acid applica-
tion was accompanied by a pronounced decrease in the
L-MAN and HVc EPSP amplitudes (Fig. 3). The L-MAN
EPSP amplitude decreased to 0.30 + 0.06 and the HVc EPSP
amplitude decreased to 0.28 ± 0.06 of their respective control
values preceding treatment. Washout of the drug was ac-
companied by recovery of the HVc EPSP amplitude to 0.98
± 0.22 of the control value and the L-MAN EPSP amplitude
to 1.26 ± 0.02 of the control value. Complete blockade was
not achieved with puffer pipette application, probably be-
cause the effective bath concentration was too low.
Kynurenic acid strongly reduced the L-MAN and HVc
EPSPs recorded from dually innervated RA neurons.
The contribution of NMDA receptor-mediated transmis-
sion in the L-MAN and HVc EPSPs was tested with the
L-MAN
HVc
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NMDA receptor antagonist D-APV (13) in 15 dually inner-
vated RA neurons. Two of these cells were examined in
normal ACSF, 12 were examined in high divalent ACSF, and
1 was examined in very high divalent ACSF supplemented
with 10 AuM bicuculline methiodide. High divalent ion con-
centrations were used to suppress polysynaptic transmission.
Regardless of the conditions, D-APV (100 ,uM applied from a
puffer pipette) significantly reduced the L-MAN EPSP am-
plitude, without exerting a significant effect on the HVc
EPSP amplitude (see Fig. 4). D-APV reduced the L-MAN
EPSP amplitude to 0.43 ± 0.03 of the control value (P <
0.0001, n = 15). In these same RA neurons, the HVc EPSP
amplitude measured in D-APV was 0.98 ± 0.06 of the control
value (P < 0.81, n = 15). In 13 cells where a successful
washout of the D-APV was obtained, the L-MAN EPSP
amplitude recovered to the control value (1.08 ± 0.08 of the
control EPSP amplitude, P < 0.322, n = 13). The HVc EPSP
exhibited an unusual washout effect, occasionally "recover-
ing" to an amplitude greater than either the control or APV
values (1.31 ± 0.10; P < 0.005 with respect to the control
conditions, P < 0.01 with respect to the APV conditions; n
= 13). Since the same "excess" recovery of the HVc EPSP
also occurred in the presence of 10 AM bicuculline methio-
dide, it is unlikely that this effect can be explained by the
presence of a D-APV-sensitive, subtype a y-aminobutyric
acid-mediated inhibitory pathway.
In addition to depressing the L-MAN EPSP amplitude,
D-APV also reduced the rise time of the L-MAN EPSP. The
time to peak of the L-MAN EPSP decreased from 12.28 ±
0.89 msec (n = 25) to 6.79 ± 0.87 msec (n = 15) in the
presence of D-APV (P < 0.0002). Although D-APV appeared
to reduce the onset slope of the L-MAN EPSP as well, from
1.06 ± 0.12 mV/msec (n = 25) to 0.67 ± 0.11 mV/msec (n =
15), this effect was not significant (P < 0.06). D-APV did not
significantly reduce either of these aspects of the HVc EPSP.
Note that the time to peak of the L-MAN EPSP measured in
the presence of D-APV approximated the control values
obtained for the HVc EPSP. Blocking NMDA receptor-
mediated components of the L-MAN EPSP unmasked a
faster component with a time course similar to the D-APV-
resistant HVc EPSP.
Although the HVc EPSP was not reduced by D-APV, it was
strongly blocked by the non-NMDA glutamate receptor
antagonist CNQX (14). Eight dually innervated RA neurons
were treated with CNQX applied from a puffer pipette. Five
cells were tested in high divalent ACSF, two were tested in
very high divalent ACSF, and one was tested in very high
divalent ACSF with 10 ,uM bicuculline methiodide. Regard-
D-APV wash
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FIG. 4. D-APV (100 ,uM applied from a puffer pipette) lowered the L-MAN EPSP amplitude, without affecting the amplitude of the HVc
EPSP, in dually innervated RA neurons. Fifteen minutes after drug application was discontinued, the L-MAN EPSP had recovered completely
(wash). Recordings were made in high divalent ACSF; the brain slice was prepared from a 50-day-old male finch. Slight dc hyperpolarization
was used to suppress spontaneous firing of action potentials in this example. In all instances, the L-MAN or HVc fiber tracts were stimulated
at t = 10 msec.
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FIG. 5. CNQX (10 FM applied from a puffer pipette) did not
significantly affect the L-MAN EPSP but almost completely abol-
ished the HVc EPSP. This dually innervated RA neuron was impaled
in a brain slice made from a 45-day-old male finch, in high divalent
ACSF. The cell is shown at its actual resting potential; L-MAN or
HVc fiber tracts were stimulated at t = 10 msec.
less of the ionic conditions, CNQX always strongly blocked
the HVc EPSP (0.27 0.03 of the control value; P < 0.0001,
n = 8), without significantly affecting the L-MAN EPSP (0.93
± 0.11 of the control value; P < 0.55, n = 8) (see Fig. 5). A
partial or complete washout was accomplished in six of the
eight cells treated with CNQX, with the HVc EPSP amplitude
recovering to 0.72 ± 0.09 of the control value. The washout
amplitude was significantly greater than the amplitude in
CNQX (P <0.0002, n =6) but was still lower than the control
value (P < 0.003, n = 6).
The onset slope of the HVc EPSP was also significantly
reduced by CNQX treatment, declining from 1.57 ± 0.14
mV/msec (n = 25) to 0.44 ± 0.04 mV/msec (n = 8) in the
presence of CNQX (P <0.0001). The time to peak amplitude
increased slightly, from 7.12 msec to 8.76 msec, but this
difference was not significant. The onset slope and time to
peak of the L-MAN EPSP were not significantly affected by
CNQX.
DISCUSSION
Electrical stimulation of the L-MAN and HVc fiber tracts
produced EPSPs in the majority of RA neurons from which
we recorded. This result suggests that L-MAN and HVc
axons form excitatory synapses on many of the same RA
neurons. The linear summation of L-MAN and HVc EPSPs
supplies evidence that the two stimulating electrodes acti-
vated different synapses on the same neuron. Assuming a
passive dendritic membrane, the linear summation of these
two EPSPs further implies that L-MAN and HVc synapses
might be electrically isolated from each other (15). In the
canary, serial electron microscopic reconstructions have
shown that L-MAN and HVc axons terminate on spinous
type IV RA neurons, and these two different synaptic pop-
ulations are randomly intermixed along the dendrite (16). If
the same is true for the RA neurons we recorded from in vitro,
then the linear interaction of the L-MAN and HVc EPSPs
could reflect a more subtle compartmentalization of the
dendrite or more complex processes involving an active
dendritic membrane.
Although L-MAN and HVc terminals evoke EPSPs from
the same RA neurons, these EPSPs appear to be mediated by
different glutamate receptor subtypes. D-APV, a specific
antagonist of the NMDA subtype of glutamate receptor (13),
blocked much of the L-MAN EPSP, even though the HVc
EPSP recorded from the same cell was largely unaffected.
Treatment with CNQX, an antagonist acting at the quis-
qualate and kainate subtypes of glutamate receptors (14),
strongly blocked the HVc EPSP but exerted no consistent
effect on the L-MAN EPSP. Despite the differential effects
ofD-APV and CNQX on these two types of EPSPs, however,
the broad spectrum glutamate receptor antagonist kynurenic
acid (12) blocked both inputs to the same extent. Electrical
stimulation of HVc and L-MAN axons thus evokes gluta-
matergic EPSPs within RA, but these EPSPs are mediated
primarily by different subtypes of glutamate receptors.
Several neural circuits use NMDA receptor activation to
generate patterned, rhythmic discharge (1, 17, 18). In the
lamprey spinal cord, application of NMDA induces oscilla-
tory activity in neurons responsible for generating the rhyth-
mic motor output necessary for swimming (19). EPSPs with
NMDA and non-NMDA components can be recorded from
the motoneurons and excitatory interneurons (premotor neu-
rons) in this spinal swimming circuit (20). The differential
activation of these NMDA and non-NMDA receptors can
modulate the output frequency of the circuit (1).
An analogous mechanism may operate to modulate electric
organ discharge in certain weakly electric fish. The electric
organ discharge (EOD) pattern is under the control of a
medullary pacemaker nucleus (PN) (21). The discharge pat-
terns of neurons within the PN, and hence the EOD, can be
modulated in two ways by afferents originating in the dien-
cephalic prepacemaker nucleus: in a smooth and graded
fashion (i.e., the jamming avoidance response, or JAR) and
in an abrupt increase in the discharge rate ("chirps") (2, 3).
Pharmacological analyses suggest that the prepacemaker
nucleus generates the JAR by activating NMDA receptors
within the pacemaker but mediates chirps by exciting non-
NMDA receptors in the same region (2, 3). Again, the
activation of distinct glutamate receptors subtypes within the
same, simple pattern generating circuit can produce strik-
ingly different behaviors.
Many HVc and RA neurons fire bursts of spikes in the
same temporal pattern as, but immediately preceding, the
bird's actual song vocalization (6). Young birds establish
their song's temporal patterns by hearing themselves sing (22,
23). RA neurons are positioned to receive premotor com-
mands from HVc and, presumably, song-related auditory
information from L-MAN (11). Our in vitro recordings from
RA neurons suggest that L-MAN and HVc axons differen-
tially activate NMDA and non-NMDA receptors during a
period when vocal plasticity is still quite pronounced. Acti-
vation of these two subtypes of glutamate receptors might be
used to modulate the output patterns of RA neurons, thus
providing a neural mechanism for generating complex and
temporally varying vocalizations.
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